Clinical Trials Logo

Hyperhidrosis clinical trials

View clinical trials related to Hyperhidrosis.

Filter by:

NCT ID: NCT06219655 Completed - Clinical trials for Hyperhidrosis Due to Autonomic Dysregulation (Disorder)

Extended Versus Limited Thoracoscopic Sympathectomy: Its Impact on Palmar and Plantar Hyperhidrosis

Start date: January 18, 2019
Phase: N/A
Study type: Interventional

Conclusions: In the context of palmar and plantar hyperhidrosis, extended thoracoscopic sympathectomy seemed to be preferred over limited thoracoscopic sympathectomy due to better overall outcomes and minimal time for hospital stays and Compensatory hyperhidrosis.

NCT ID: NCT06113978 Completed - Hyperhidrosis Clinical Trials

Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Patients Below 18

MISforPPH
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

In this study, the investigators aim to present fifteen years' experience of thoracoscopic sympathetic chain interruption for primary palmar hyperhidrosis in children and adolescents; evaluation of 3 different techniques (sympathectomy, sympathotomy, and clipping) regarding demographic data, surgical outcomes, complications, compensatory sweating, and patients' satisfaction.

NCT ID: NCT05875285 Not yet recruiting - Hyperhidrosis Clinical Trials

Methotrexate Iontophoresis Versus Coal Tar Ointement in the Treatment of Primary Palmer Hyper Hidrosis

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to compare the therapeutic effect of methotrexate iontophoresis versus coal tar ointment on the the treatment of primary palmer hyperhidrosis?

NCT ID: NCT05863104 Completed - Clinical trials for Primary Axillary Hyperhidrosis

Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis

Start date: March 7, 2023
Phase: Phase 2
Study type: Interventional

The aim of this study is to evaluate the safety, tolerability and systemic exposure (in a subset of patients) of topical administration of 1% GPB in adolescents with severe primary axillary hyperhidrosis.

NCT ID: NCT05860972 Recruiting - Clinical trials for Hyperhidrosis Primary Focal Axilla

Evaluation of Safety and Efficacy of Morpheus8 Applicator for the Treatment of Focal Hyperhidrosis of the Axillae Using Radio Frequency

Start date: March 9, 2023
Phase: N/A
Study type: Interventional

The InMode radio frequency Pro System with the Morpheus8 Applicator is a computerized system generating radio frequency energy, based on the underlying technology of Fractional RF. The Morpheus8 Applicator and 24 pin tip is used for the treatment of primary hyperhidrosis of the axillae

NCT ID: NCT05805696 Recruiting - Hyperhidrosis Clinical Trials

Treatment and Mapping of Impostor Phenomenon

Start date: May 15, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate persons/patients with different skin diseases or pain to evaluate whether unhealthy perfectionism, stress, anxiety, impostor phenomenon (inability to realistically assess your competence and skills) and lack of self-compassion (a positive attitude towards ourselves), have impact on symptoms, handling, and treatment regarding some dermatological diseases/pain.

NCT ID: NCT05737914 Not yet recruiting - Clinical trials for Primary Palmar Hyperhydrosis

Bilateral Endoscopic Thoracic T3 Sympathectomy Versus T3 Radiofrequency Ablation for Primary Palmar Hyperhidrosis

Start date: February 2023
Phase: N/A
Study type: Interventional

Primary hyperhidrosis disease is characterized by much more sweating above the needs for thermoregulation, which is worsen by increased temperature and emotional factors it can be seen in the palms of the hands, soles of the feet/ face and so on. Hyperhidrosis usually starts since childhood and continuous throughout life aggravated by emotional stress or by high environmental temperature. Many lines of treatment were tried such as anticholinergic drug, physiotherapy. Endoscope thoracic sympathectomy and radio frequency with phenol injection.

NCT ID: NCT05546710 Withdrawn - Hyperhidrosis Clinical Trials

miraDry Post Market Tumescent Anesthesia Study

Start date: November 2022
Phase: N/A
Study type: Interventional

This clinical trial will collect data on the safety and efficacy of the miraDry treatment when High Volume Anesthesia (Tumescent Anesthesia) is used as an alternate method of anesthetizing the axilla prior to the miraDry System being used. MiraDry system was FDA cleared in 2011 for the treatment of primary axillary hyperhidrosis. The miraDry system is also CE-marked.

NCT ID: NCT05501444 Completed - Hyperhidrosis Clinical Trials

Antiperspirant in the Treatment of Residual Limp Hyperhidrosis for Prosthetic Users

Start date: August 9, 2022
Phase: N/A
Study type: Interventional

The aim of the present pilot study is to evaluate the effect of antiperspirant to treat residual limb hyperhidrosis with the emphasis on the utility of the iodine-starch test to identify the location of the sweating.

NCT ID: NCT05403710 Recruiting - Clinical trials for Hidradenitis Suppurativa

Botulinum Toxin Therapy in Hidradenitis Suppurativa

HS
Start date: June 7, 2022
Phase:
Study type: Observational

This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chronic inflammatory skin disease Hidradenitis Suppurativa (HS). In this study, the investigators will test the hypothesis that inhibiting neuropeptide activity with botulinum toxin reduces pathogenic inflammation.